Raia DrogasilBSP:RADL3 -2.04%91 Pretax Margin % is 1.20% as of Mar. 2026, which is 71% below its 10-year median of 4.10. GuruFocus rates BSP:RADL3 with a GF Score™ of 91/100 and a GF Value™ of R$29.96 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Raia Drogasil ranks worse than 53.6% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Raia Drogasil's Pre-Tax Income for the
three
months ended in Mar. 2026 was R$127 Mil. Raia Drogasil's Revenue for the
three
months ended in Mar. 2026 was R$10,569 Mil. Therefore, Raia Drogasil's pretax margin for the quarter that ended in Mar. 2026 was 1.20%.
The historical rank and industry rank for Raia Drogasil's Pretax Margin % or its related term are showing as below:
BSP:RADL3'
s Pretax Margin % Range Over the Past 10 Years
Min: 3.07 Med: 4.1 Max: 5.29
Current: 3.07
BSP:RADL3's Pretax Margin % is ranked worse than 53.6% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 4
vs BSP:RADL3: 3.07
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Raia Drogasil Pretax Margin % Related Terms
Raia Drogasil Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Raia Drogasil's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Raia Drogasil's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raia Drogasil Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Raia Drogasil's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raia Drogasil (BSP:RADL3) has a Pretax Margin % of 1.20% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Raia Drogasil and its competitors. This is 71% below median its historical median of 4.10. Over the past decade, Raia Drogasil's Pretax Margin % has ranged from 3.07 to 5.29. According to the industry distribution chart, Raia Drogasil ranks #357 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 53.6%.
Is Raia Drogasil's Pretax Margin % too high?
Raia Drogasil's current Pretax Margin % of 1.20% is 71% below median its 10-year median of 4.10. Over the past 10 years, this metric has ranged from a low of 3.07 to a high of 5.29. The Healthcare Providers & Services industry median Pretax Margin % is 4.00. Raia Drogasil's value of 1.20% is 70% below this industry median. Based on the distribution chart, Raia Drogasil ranks #357 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Raia Drogasil has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raia Drogasil's Pretax Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Raia Drogasil ranks #357 out of 666 companies for Pretax Margin %. This places Raia Drogasil in the lower half of its industry. The industry median Pretax Margin % is 4.00. Raia Drogasil's value of 1.20% is 70% below this benchmark. Historically, Raia Drogasil's own Pretax Margin % has ranged from 3.07 to 5.29 over the past decade. While the company's 10-year median is 4.10 vs. the industry median of 4.00, Raia Drogasil has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.00, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raia Drogasil's current Pretax Margin % of 1.20% is 70% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Raia Drogasil and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raia Drogasil's current Pretax Margin % is 1.20%, which is 71% below median its own 10-year median of 4.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raia Drogasil stock overvalued right now?
Based on GuruFocus' analysis, Raia Drogasil (BSP:RADL3) is currently considered Significantly Undervalued. The stock's GF Value™ is R$29.96, compared to a current price of R$16.81 — trading 43.9% below its estimated fair value. The current Pretax Margin % is 1.20%, which is 71% below median its 10-year median of 4.10 and 70% below the Healthcare Providers & Services industry median of 4.00. Raia Drogasil's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Raia Drogasil (BSP:RADL3), the current Pretax Margin % is 1.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raia Drogasil (BSP:RADL3) Overvalued in 2026?
Based on GuruFocus' analysis, Raia Drogasil stock appears to be undervalued.
The current stock price of R$16.81 is trading 43.9% below its estimated GF Value™ of R$29.96.
GuruFocus considers Raia Drogasil to be Significantly Undervalued.
Key valuation signals for BSP:RADL3:
Pretax Margin %: 1.20% (71% below median its 10-year median of 4.10)
GF Value™: R$29.96 vs. price of R$16.81 (43.9% below fair value)
Industry Position: 70% below the Healthcare Providers & Services median (#357 of 666)
No single metric tells the full story. See the BSP:RADL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.
91GF Score
Get the complete analysis for BSP:RADL3
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:RADL3 has been successfully added to your 
